Zika Virus Testing Industry

The global market for Zika virus testing is projected to reach a valuation of USD 341.6 million by the year 2030, according to a new report released by Grand View Research, Inc. The market is expected to grow at a compound annual growth rate (CAGR) of 7.3% over the period from 2024 to 2030. One of the key factors contributing to this growth trajectory is the Zika virus outbreak that occurred in 2016. This outbreak significantly influenced public health strategies, leading to the expansion of diagnostic surveillance systems and enhanced response frameworks globally. The widespread transmission observed in 2016 was largely attributed to international travel, which facilitated the spread of the virus across borders.

Another critical development driving the demand for Zika virus testing market is the scientifically recognized link between Zika virus infections during pregnancy and microcephaly—a severe neurological condition observed in newborns. This association has intensified the urgency for early detection and accurate diagnosis, further fueling market growth.

The increasing need for Zika virus testing is also being propelled by government-backed preparedness measures, as well as support from global health organizations such as the United Nations Children’s Fund (UNICEF). Various national and international health bodies have been investing in stockpiling diagnostic kits and establishing emergency preparedness protocols. These initiatives are focused not only on regions currently experiencing outbreaks but also on populations that are considered immunologically naïve—those who have not been previously exposed to the virus—particularly in parts of Asia and Africa.

Although many of these developing nations are not presently classified as endemic zones for the Zika virus, they possess environmental conditions conducive to future outbreaks. Factors such as rising temperatures, high humidity, and frequent precipitation create favorable conditions for the proliferation of Aedes aegypti mosquitoes—the primary vectors responsible for transmitting the virus. The confirmed presence of these mosquito populations in such regions adds to the potential risk and emphasizes the importance of proactive testing and surveillance programs.

As a result, both endemic and at-risk non-endemic areas are expected to drive the need for advanced diagnostic tools and reliable testing infrastructure in the coming years, sustaining steady market expansion through 2030.

Curious about the Zika Virus Testing Market, Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

Zika Virus Testing Market Segments Highlights:

  • The serological test dominated the market and accounted for the largest revenue share of 51.1% in 2023.
  • Molecular tests are expected to grow at a CAGR of 8.8% over the forecast period attributed to the continuous advancements in molecular diagnostic technologies, such as polymerase chain reaction (PCR) and nucleic acid amplification.
  • Clinical laboratories led the market and accounted for the largest revenue share of 47.4% in 2023.
  • Hospitals are expected to grow at a CAGR of 7.3% over the forecast period attributed to the rising demand for diagnosis and treatment of Zika virus and the high need for accurate and quick tests.

Zika Virus Testing Market Report Segmentation

Grand View Research has segmented the global zika virus testing market on the basis of test, end use, and region:

Zika Virus Testing Test Outlook (Revenue, USD Million, 2018 - 2030)

  • Molecular Test
  • Serological Test

Zika Virus Testing End use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals/Clinics
  • Diagnostic Laboratory
  • Others

Zika Virus Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US States
    • US Territories
  • Europe
    • Continental Europe
    • Caribbean(EU)
  • Asia Pacific
    • Singapore
    • Vietnam
    • Indonesia
    • Thailand
  • Latin America
    • Brazil
    • Colombia
  • Middle East and Africa (MEA)
    • South Africa

Key Zika Virus Testing Company Insights

  • Abbott
  • DiaSorin S.p.A.
  • Hoffmann-La Roche Ltd.
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • Chembio Diagnostic Systems, Inc.
  • SD Biosensors, Inc.
  • Biocan Diagnostics
  • ARUP Laboratories
  • Viatris Inc.

Order a free sample PDF of the Zika Virus Testing Market Intelligence Study, published by Grand View Research.